GalK limits type I-F CRISPR-Cas expression in a CRP-dependent manner

Area of Science:

• Microbiology
• Bacterial Genetics
• Molecular Biology

Background:

• CRISPR-Cas systems provide adaptive immunity in bacteria against foreign genetic elements like phages and plasmids.
• While CRISPR-Cas immunity mechanisms are well-studied, their regulatory processes remain less understood.
• Previous research indicated that the galactose metabolism gene galM influences cas operon expression in Pectobacterium atrosepticum.

Purpose of the Study:

• To investigate the regulatory mechanisms of CRISPR-Cas systems in bacteria.
• To explore the role of galactose metabolism in modulating CRISPR-Cas immunity.
• To characterize the impact of the galK gene on cas operon and CRISPR array expression.

Main Methods:

• Construction of suicide lacZ-reporter plasmids with antibiotic resistance cassettes for single-copy chromosomal integration.
• Utilizing integrative reporters to maintain natural gene expression and reflect regulation in a genomic context.
• Generating deletion mutants for the galK gene in Pectobacterium atrosepticum to assess its effect on CRISPR-Cas components.

Main Results:

• Deletion of the galK gene resulted in significantly elevated cas operon expression.
• The observed increase in cas expression due to galK deletion was dependent on the CRP protein.
• CRISPR array expression remained unaffected by the deletion of the galK gene.
• These findings link the host cell's metabolic state to the induction of CRISPR-Cas immunity.

Conclusions:

• The metabolic status of the bacterial host cell is intrinsically linked to the regulation and induction of CRISPR-Cas immunity.
• The galK gene, involved in galactose metabolism, plays a regulatory role in controlling cas operon expression.
• CRISPR-Cas immunity is subject to dynamic regulation influenced by cellular metabolic pathways, highlighting a complex interplay between host metabolism and defense.